Measuring red blood cell lifespan in sickle cell disease
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study uses a harmless vitamin (biotin) to label your red blood cells and track how long they survive. It aims to understand how different blood disorders affect red blood cell lifespan, which may help improve treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have sickle cell disease, thalassemia, or another inherited red blood cell disorder
- Your disease is stable (not in crisis) or you have had a bone marrow transplant
- You have not taken biotin supplements or eaten raw eggs in the last 30 days
- You have not had a red blood cell transfusion in the last 3 months
- If you are a woman who can become pregnant, you agree to use birth control for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and urine samples from adults to help researchers understand diseases affecting blood vessels. Your donation helps scientists develop better treatments.
This study collects blood samples to learn more about sickle cell-related genetics and biology. You might benefit indirectly by helping researchers understand the condition, even though this is laboratory research rather than a medication trial.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
This study looks at whether red blood cell exchange (a treatment that replaces some of your blood with donor blood) can help reduce inflammation and blood clotting problems in people with sickle cell disease. If you are already on this treatment, it may help doctors understand how it affects your body.
This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.
This trial tests an investigational drug called DISC-3405 in people with sickle cell disease (SCD) to see if it is safe and how it affects your body. It may be an option if you have certain SCD complications or lab results.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.